This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Results

Authoring team

Only 60% of the 688 randomised patients completed the 2 year trial.

During the first year:

  • the orlistat group lost 10.2% body weight vs. 6.1%

During the second year:

  • those who continued on orlistat gained 2% body weight
  • those who continued on placebo gained 2.5% body weight
  • those who swapped from placebo to orlistat lost 0.9%
  • those who swapped from orlistat to placebo gained 4%

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.